Publications by authors named "Jean Brochier"
Immunol Cell Biol
August 2002
Article Synopsis
- Type 1 (T1) cytokine responses are essential for clearing hepatitis C virus but can also lead to liver damage, making the balance between T1 and T2 responses important for treatment outcomes.
- A pilot study was conducted on treatment-naïve hepatitis C patients receiving IFN alpha 2b and ribavirin to identify immunological markers that could predict therapy success.
- Key findings showed that high baseline levels of sCD30 were associated with better virological responses to treatment, indicating that a T2 cytokine profile may enhance the effectiveness of therapy.
